These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6502954)

  • 1. [Cerebral vessels and thrombosis].
    Miyakawa T; Sakuragawa N
    Rinsho Ketsueki; 1984 Jul; 25(7):1018-26. PubMed ID: 6502954
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental and clinical studies on oral urokinase and lysyl-plasminogen. Thrombolytic therapy for cerebral thrombosis].
    Naito I
    Rinsho Ketsueki; 1984 Jul; 25(7):1027-35. PubMed ID: 6389929
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical effects and basic studies of thrombolytic therapy on cerebral thrombosis.
    Terashi A; Kobayashi Y; Katayama Y; Inamura K; Kazama M; Abe T
    Semin Thromb Hemost; 1990 Jul; 16(3):236-41. PubMed ID: 2122521
    [No Abstract]   [Full Text] [Related]  

  • 4. [Indications for the use of thrombolytics in cases of cerebrovascular thrombosis also treated with hyperbaric oxygenation (2 ATA)].
    Larcan A; Laprevote-Heully MC; Lambert H; Alexandre P; Picard L; Chrisment N
    Therapie; 1977; 32(3):259-70. PubMed ID: 929497
    [No Abstract]   [Full Text] [Related]  

  • 5. Retrospective study on the efficacy of using urokinase therapy.
    Matsuo O; Kosugi T; Mihara H; Ohki Y; Matsuo T
    Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):684-8. PubMed ID: 506651
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of oral urokinase and its clinical application.
    Abe T; Kazama M; Naito I; Kinoshita T; Sasaki K
    New Istanbul Contrib Clin Sci; 1982; 13(3):161-70. PubMed ID: 6760114
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombolytic therapy using urokinase in cerebral thrombosis (author's transl)].
    Sakuragawa N
    Nihon Naika Gakkai Zasshi; 1979 May; 68(5):486-9. PubMed ID: 469353
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombolytic therapy for acute cerebral vascular occlusion.
    Zhu T; Liu F; Luo Q; Li Y; Wang C
    Chin Med J (Engl); 1995 Dec; 108(12):930-1. PubMed ID: 8728948
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cerebral thrombo-embolism--pathophysiology and managements (author's transl)].
    Nagashima C; Kim S; Hashimoto I
    Rinsho Ketsueki; 1977 Jun; 18(6):746-55. PubMed ID: 916206
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical problem-solving: diagnosing spousal abuse.
    Sunman W; Jack C; Lye M
    N Engl J Med; 1995 Dec; 333(25):1710; author reply 1711. PubMed ID: 7477230
    [No Abstract]   [Full Text] [Related]  

  • 11. [Local therapeutic fibrinolysis in ischemic cerebrovascular insults: initial findings in 6 patients].
    Tsakiris DA; Stock KW; Mürner J; Radü EW; Mäder G; Marbet GA
    Schweiz Med Wochenschr; 1993 Sep; 123(38):1784-9. PubMed ID: 8211030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is a combination of urokinase and Lys-plasminogen by regional infusion indicated in ischaemia due to popliteal or infra-popliteal thrombosis?
    Giraud C; Joffre F; Puel P; Cerene A
    Haemostasis; 1986; 16 Suppl 3():79-82. PubMed ID: 3770547
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thrombolytic treatment of deep venous thrombosis].
    Martínez-Brotons F; Cairols MA
    Sangre (Barc); 1984; 29(4-C):762-6. PubMed ID: 6515512
    [No Abstract]   [Full Text] [Related]  

  • 14. [Is it permissible to use the combination urokinase-plasminogen by local administration in ischemias caused by popliteal or sub-popliteal thrombosis?].
    Giraud C; Joffre F; Puel P; Cerene A
    Haemostasis; 1986; 16 Suppl 4():83-6. PubMed ID: 3770560
    [No Abstract]   [Full Text] [Related]  

  • 15. [A rat middle cerebral artery thrombosis model for evaluation of thrombolytic and antithrombotic agents].
    Liu XG; Xu LN
    Yao Xue Xue Bao; 1995; 30(9):662-7. PubMed ID: 8701741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of an antithrombotic agent (MD-805) on progressing cerebral thrombosis.
    Kobayashi S; Kitani M; Yamaguchi S; Suzuki T; Okada K; Tsunematsu T
    Thromb Res; 1989 Feb; 53(3):305-17. PubMed ID: 2655161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations of alpha 2-plasmin inhibitor, antithrombin III, plasminogen in the serum of patients of cerebral thrombosis infused with urokinase.
    Takada A; Takada Y; Uemura K; Nakajima S; Ryu H; Ninchoji T
    Thromb Res; 1979; 15(5-6):889-94. PubMed ID: 115108
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intra-arterial urokinase-lys-plasminogen thrombolytic treatment. An alternative].
    Debure C; Roncatot M; Pernes JM; Gaux JC; Aiach M; Fiessinger JN
    Presse Med; 1984 Apr; 13(18):1152-3. PubMed ID: 6232554
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant and thrombolytic therapy for cerebral embolism of cardiac origin.
    Sato Y; Mizoguchi K; Sato Y; Ohkita Y; Kaji M
    Kurume Med J; 1986; 33(2):89-95. PubMed ID: 3821053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.